QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
QQQ   432.61 (+0.36%)
AAPL   169.74 (-1.71%)
MSFT   417.06 (+0.83%)
META   502.47 (+0.45%)
GOOGL   155.28 (+0.27%)
AMZN   183.99 (+0.20%)
TSLA   156.71 (-2.95%)
NVDA   878.21 (+2.12%)
AMD   163.79 (+2.16%)
NIO   3.88 (-0.26%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.85 (+0.40%)
GE   156.46 (+1.80%)
CGC   6.84 (-2.01%)
DIS   114.11 (+1.03%)
AMC   2.78 (+12.55%)
PFE   25.83 (-0.31%)
PYPL   63.90 (+0.61%)
XOM   118.91 (-0.64%)
NYSE:ELMD

Electromed (ELMD) Stock Price, News & Analysis

$14.48
-0.17 (-1.16%)
(As of 02:54 PM ET)
Today's Range
$14.30
$14.80
50-Day Range
$10.02
$17.61
52-Week Range
$8.80
$17.85
Volume
19,302 shs
Average Volume
28,210 shs
Market Capitalization
$124.67 million
P/E Ratio
32.18
Dividend Yield
N/A
Price Target
N/A
ELMD stock logo

About Electromed Stock (NYSE:ELMD)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

ELMD Stock Price History

ELMD Stock News Headlines

StockNews.com Upgrades Electromed (NYSE:ELMD) to Strong-Buy
Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
ELMD Aug 2024 7.500 put
ELMD May 2024 10.000 call
Your eBook: Mastering Earnings Announcements Trading
Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).
Recap: Electromed Q2 Earnings
Electromed Inc.
Earnings Outlook For Electromed
Q4 2023 Electromed Inc Earnings Call
See More Headlines
Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
4/16/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Employees
170
Year Founded
N/A

Profitability

Net Income
$3.17 million
Pretax Margin
10.32%

Debt

Sales & Book Value

Annual Sales
$48.07 million
Cash Flow
$0.44 per share
Book Value
$4.40 per share

Miscellaneous

Free Float
7,512,000
Market Cap
$124.85 million
Optionable
Optionable
Beta
0.43
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

ELMD Stock Analysis - Frequently Asked Questions

How have ELMD shares performed in 2024?

Electromed's stock was trading at $10.91 at the beginning of 2024. Since then, ELMD shares have increased by 32.7% and is now trading at $14.48.
View the best growth stocks for 2024 here
.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSE:ELMD) announced its earnings results on Tuesday, February, 13th. The company reported $0.19 earnings per share (EPS) for the quarter. The firm had revenue of $13.69 million for the quarter. Electromed had a net margin of 7.62% and a trailing twelve-month return on equity of 10.32%.

How do I buy shares of Electromed?

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ELMD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners